Al-Ani RM. Ear, nose, and throat manifestations of COVID-19 and its vaccines. World J Clin Cases 2022; 10(25): 8808-8815 [PMID: 36157654 DOI: 10.12998/wjcc.v10.i25.8808]
Corresponding Author of This Article
Raid M Al-Ani, MBChB, Full Professor, Department of Surgery/Otolaryngology, University of Anbar, College of Medicine, AL-Thaela, Ramadi 31001, Anbar, Iraq. med.raed.alani2003@uoanbar.edu.iq
Research Domain of This Article
Otorhinolaryngology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Sep 6, 2022; 10(25): 8808-8815 Published online Sep 6, 2022. doi: 10.12998/wjcc.v10.i25.8808
Ear, nose, and throat manifestations of COVID-19 and its vaccines
Raid M Al-Ani
Raid M Al-Ani, Department of Surgery/Otolaryngology, University of Anbar, College of Medicine, Ramadi 31001, Anbar, Iraq
Author contributions: Raid M Al-Ani has all contributions, regarding the design of the study, searching for the relevant references, structuring of the manuscript, design of the table, and writing the draft; I read and approved the final draft.
Conflict-of-interest statement: The author declares that there is no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Raid M Al-Ani, MBChB, Full Professor, Department of Surgery/Otolaryngology, University of Anbar, College of Medicine, AL-Thaela, Ramadi 31001, Anbar, Iraq. med.raed.alani2003@uoanbar.edu.iq
Received: April 2, 2022 Peer-review started: April 2, 2022 First decision: May 30, 2022 Revised: June 1, 2022 Accepted: July 25, 2022 Article in press: July 25, 2022 Published online: September 6, 2022 Processing time: 145 Days and 17.4 Hours
Core Tip
Core Tip: The most common otorhinolaryngological manifestations of coronavirus disease 2019 (COVID-19) are olfactory dysfunctions rather than other symptoms (sore throat, nasal obstruction, deafness, dysphonia, tinnitus, etc.). They might be present alone or associated with other common features of the disease (fever, cough, myalgia, headache and dyspnea). Adverse effects of the COVID-19 vaccines include local injection pain, fever, myalgia, headache, and others. Otorhinolaryngological side effects like Bell’s palsy, anosmia and deafness due to COVID-19 vaccines are reported in the literature as individual cases or small case series. We review the currently available evidence regarding the otorhinolaryngological features of COVID-19 or after vaccination.
